IT8012595A0 - Ossidi di ammino eteri utilizzabili particolarmente come anestetici analgesici e spasmolitici e loro metodo di fabbricazione - Google Patents
Ossidi di ammino eteri utilizzabili particolarmente come anestetici analgesici e spasmolitici e loro metodo di fabbricazioneInfo
- Publication number
- IT8012595A0 IT8012595A0 IT8012595A IT1259580A IT8012595A0 IT 8012595 A0 IT8012595 A0 IT 8012595A0 IT 8012595 A IT8012595 A IT 8012595A IT 1259580 A IT1259580 A IT 1259580A IT 8012595 A0 IT8012595 A0 IT 8012595A0
- Authority
- IT
- Italy
- Prior art keywords
- spasmolytic
- anesthetics
- analgesic
- manufacture
- amino ether
- Prior art date
Links
- 230000000202 analgesic effect Effects 0.000 title 1
- 229940035674 anesthetics Drugs 0.000 title 1
- 239000000812 cholinergic antagonist Substances 0.000 title 1
- 239000003193 general anesthetic agent Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- SBOJXQVPLKSXOG-UHFFFAOYSA-N o-amino-hydroxylamine Chemical compound NON SBOJXQVPLKSXOG-UHFFFAOYSA-N 0.000 title 1
- 230000002048 spasmolytic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7917986A FR2460919A1 (fr) | 1979-07-11 | 1979-07-11 | Amino-ethers oxydes, leur procede de preparation et leur application en therapeutique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IT8012595A0 true IT8012595A0 (it) | 1980-07-11 |
| IT1136190B IT1136190B (it) | 1986-08-27 |
Family
ID=9227765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT12595/80A IT1136190B (it) | 1979-07-11 | 1980-07-11 | Ossidi di ammino eteri utilizzabili particolarmente come anestetici analgesici e spasmolitici e loro metodo di fabbricazione |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4301163A (it) |
| JP (1) | JPS5615250A (it) |
| BE (1) | BE884212A (it) |
| CA (1) | CA1148547A (it) |
| CH (1) | CH644348A5 (it) |
| DE (1) | DE3026201A1 (it) |
| ES (1) | ES493092A0 (it) |
| FR (1) | FR2460919A1 (it) |
| GB (1) | GB2054588B (it) |
| IT (1) | IT1136190B (it) |
| NL (1) | NL190237C (it) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4824868A (en) * | 1982-09-07 | 1989-04-25 | Ciba-Geigy Corporation | Propylamine derivatives useful for the treatment of dementia |
| US4692469A (en) * | 1982-09-07 | 1987-09-08 | Ciba-Geigy Corporation | Propylamine derivatives |
| ATE28069T1 (de) * | 1982-09-07 | 1987-07-15 | Ciba Geigy Ag | Propylamin-derivate, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung. |
| ZW6584A1 (en) * | 1983-04-18 | 1985-04-17 | Glaxo Group Ltd | Phenethanolamine derivatives |
| US5245080A (en) * | 1989-02-20 | 1993-09-14 | Jouveinal Sa | (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-N-propylamine, process for preparing it and its therapeutical use |
| US5266599A (en) * | 1989-02-20 | 1993-11-30 | Jouveinal S.A. | Use of (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-n-propylamine to increase gastric discharge in a subject |
| FR2643369B1 (fr) * | 1989-02-20 | 1991-07-05 | Jouveinal Sa | La (+) 1-((3,4,5-trimethoxy) benzyloxymethyl)-1-phenyl-n,n-dimethyl-n-propylamine, son procede de preparation et son application en therapeutique |
| JPH06509087A (ja) * | 1991-07-05 | 1994-10-13 | メルク シヤープ エンド ドーム リミテツド | 芳香族化合物、それらを含む医薬組成物、及び治療におけるそれらの使用 |
| AU664188B2 (en) * | 1991-07-05 | 1995-11-09 | Merck Sharp & Dohme Limited | Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| WO1993001165A2 (en) * | 1991-07-10 | 1993-01-21 | Merck Sharp & Dohme Limited | Aromatic compounds, compositions containing them and their use in therapy |
| US5495047A (en) * | 1991-07-10 | 1996-02-27 | Merck, Sharp & Dohme (Ltd.) | Fused tricyclic compounds, pharmaceutical compositions containing them and their use in therapy |
| US5328927A (en) * | 1992-03-03 | 1994-07-12 | Merck Sharpe & Dohme, Ltd. | Hetercyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
| GB9211193D0 (en) * | 1992-05-27 | 1992-07-08 | Merck Sharp & Dohme | Therapeutic agents |
| AU4718093A (en) * | 1992-07-31 | 1994-03-03 | Merck Sharp & Dohme Limited | Substituted amines as tachykinin receptor antagonists |
| US5948820A (en) * | 1994-08-22 | 1999-09-07 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzene compound and pharmaceutical use thereof |
| DE69524962T4 (de) * | 1994-08-22 | 2003-08-28 | Mitsubishi Pharma Corp., Osaka | Benzolderivate und deren medizinische verwendung |
| MXPA04006709A (es) | 2002-01-11 | 2004-10-04 | Sankyo Co | Derivados de aminoalcohol o derivados de acido fosfonico y composiciones farmaceuticas que los contienen. |
| US20040010035A1 (en) * | 2002-07-15 | 2004-01-15 | Ciociola Arthur A. | Gastrointestinal compositions |
| US6986901B2 (en) * | 2002-07-15 | 2006-01-17 | Warner-Lambert Company Llc | Gastrointestinal compositions |
| EP1549302A1 (en) * | 2002-07-10 | 2005-07-06 | Warner-Lambert Company LLC | Gastrointestinal compositions comprising gaba derivatives |
| AU2003281172A1 (en) * | 2002-07-10 | 2004-02-02 | Warner-Lambert Company Llc | Gastrointestinal Compositions |
| KR20110136901A (ko) | 2004-02-24 | 2011-12-21 | 상꾜 가부시키가이샤 | 아미노 알코올 화합물 |
| SE0400968D0 (sv) * | 2004-04-14 | 2004-04-14 | Astrazeneca Ab | Aryl glycine ether derivatives and their use |
| US7879913B2 (en) * | 2005-06-28 | 2011-02-01 | Catholic Healthcare West | Iptakalim hydrochloride for decreasing nicotine use |
| RU2008152751A (ru) * | 2006-06-06 | 2010-07-20 | Антиб Терапьютикс Инк. (Ca) | Соли тримебутина и n-десметилтримебутина |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2649445A (en) * | 1948-02-28 | 1953-08-18 | Bristol Lab | Chloracetic acid ester of diphenyl ethanols |
| ES251290A1 (es) * | 1958-08-21 | 1960-04-01 | Parke Davis & Co | Un procedimiento para la producciën de alcohilaminas arilsustituidas |
| GB1119835A (en) * | 1964-07-20 | 1968-07-17 | Analyses Et De Rech S Biolog M | Process for the preparation of basic ethers |
| US4194009A (en) * | 1974-01-10 | 1980-03-18 | Eli Lilly And Company | Aryloxyphenylpropylamines for obtaining a psychotropic effect |
| US4207343A (en) * | 1978-06-22 | 1980-06-10 | Eli Lilly And Company | 1-Phenyl-3-(substituted phenoxy)propylamines |
-
1979
- 1979-07-11 FR FR7917986A patent/FR2460919A1/fr active Granted
-
1980
- 1980-06-21 NL NLAANVRAGE8003601,A patent/NL190237C/xx not_active IP Right Cessation
- 1980-06-30 CH CH502680A patent/CH644348A5/fr not_active IP Right Cessation
- 1980-07-01 US US06/164,931 patent/US4301163A/en not_active Expired - Lifetime
- 1980-07-04 ES ES493092A patent/ES493092A0/es active Granted
- 1980-07-08 BE BE0/201322A patent/BE884212A/fr not_active IP Right Cessation
- 1980-07-10 GB GB8022612A patent/GB2054588B/en not_active Expired
- 1980-07-10 DE DE19803026201 patent/DE3026201A1/de active Granted
- 1980-07-11 CA CA000356003A patent/CA1148547A/en not_active Expired
- 1980-07-11 JP JP9408580A patent/JPS5615250A/ja active Granted
- 1980-07-11 IT IT12595/80A patent/IT1136190B/it active
Also Published As
| Publication number | Publication date |
|---|---|
| IT1136190B (it) | 1986-08-27 |
| NL190237C (nl) | 1993-12-16 |
| FR2460919B1 (it) | 1983-11-10 |
| DE3026201C2 (it) | 1990-11-08 |
| US4301163B1 (it) | 1990-01-23 |
| FR2460919A1 (fr) | 1981-01-30 |
| GB2054588A (en) | 1981-02-18 |
| JPS5615250A (en) | 1981-02-14 |
| US4301163A (en) | 1981-11-17 |
| CH644348A5 (fr) | 1984-07-31 |
| NL8003601A (nl) | 1981-01-13 |
| NL190237B (nl) | 1993-07-16 |
| DE3026201A1 (de) | 1981-02-26 |
| BE884212A (fr) | 1981-01-08 |
| GB2054588B (en) | 1983-06-29 |
| ES8103020A1 (es) | 1981-02-16 |
| CA1148547A (en) | 1983-06-21 |
| ES493092A0 (es) | 1981-02-16 |
| JPS6253504B2 (it) | 1987-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1136190B (it) | Ossidi di ammino eteri utilizzabili particolarmente come anestetici analgesici e spasmolitici e loro metodo di fabbricazione | |
| AR225301A1 (es) | Procedimiento para preparar benzamidas nortropil-alquilicas | |
| IT8049287A0 (it) | Contenitore multistrato e metodo di fabbricazione dello stesso | |
| SE7803535L (sv) | Magnethuvud och metod for tillverkning derav | |
| NL930051I1 (nl) | Lokaal anesthetisch mengsel voor topicale toepassing en werkwijze ter bereiding daarvan | |
| ES497663A0 (es) | Metodo para fabricar un cuerpo ceramico | |
| IT8349135A0 (it) | Poliossialchileneteri di glicerina o di 1,2-propandiolo esterificati con acido grasso e/o acido isostearico, loro produzione e loro impiego come agenti addensanti o solubilizzanti | |
| IT1065311B (it) | Metodo di preparazione ed impiego come algicida di un polielettrolito polietilenico | |
| AR219401A1 (es) | Bobinas de nucleo de aire y procedimiento para fabricarlas | |
| IT1193348B (it) | Composizione farmaceutica a base di acido tiazolidin-4-carbossilico per il trattamento di malattie neoplastiche e metodi di preparazione | |
| IT8048615A0 (it) | Pirazinobenzodiazepine loro preparazione e loro impiego come medicamenti | |
| IT1195309B (it) | Composti ai-77 loro sali farmaceuticamente accettabile e procedimento per produrli | |
| BR7904194A (pt) | Processo para sintese concomitante de esteres de alcanol e de glicol vicinal | |
| IT1126509B (it) | Benzimidi ad attivita' anestetica locale e antiaritmica,processo per la loro preparazione e composizioni farmaceutiche che le contengono | |
| IT1171411B (it) | Amminoglucosidi ammidinati procentimento per loro preparazione e loro impiego come medicamenti | |
| IT1070015B (it) | Eteramine secondarie e processo per la loro preparazione | |
| BR7606350A (pt) | Transformador aperfeicoado e processo para fabrica-lo | |
| ATA495176A (de) | Verfahren zur herstellung neuer homophthalimide und ihrer salze | |
| SE7811794L (sv) | Magnethuvud och metod for framstellning derav | |
| PL197115A1 (pl) | Sposob wytwarzania przedzy rdzeniowej i urzadzenie do wytwarzania przedzy rdzeniowej | |
| ES535791A0 (es) | Procedimiento para preparar un nucleo magnetico de material ferromagnetico de caracter oxido. | |
| AT376203B (de) | Verfahren zur herstellung des neuen n-(1-methyl-2-pyrrolidinylmethyl)-2,3-dimethoxy 5- methylsulfamoylbenzamids, seiner salze, oxide und optisch aktiven isomeren | |
| ZW17581A1 (en) | N-(1-allyl-2-pyrrolidinyl-methoxy 4-amino 5-methysulfamoyl benzamide its method of preparation and its use as a medicament | |
| FR2332979A1 (fr) | Halogenures d'acides sulfamiques et leur preparation | |
| IT1193321B (it) | Procedimento per la produzione contemporanea di combustibile per reattori e di combustibile diesel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19970729 |